Ken Grime
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 19
- Pharmacogenetics and Drug Metabolism 17
- Drug-Induced Hepatotoxicity and Protection 5
- Oncology 17
- Drug Transport and Resistance Mechanisms 12
- Co-authors
- Robert J. Riley (9 shared papers)Dermot F. McGinnity (5 shared papers)Matthew G. Soars (2 shared papers)Jane R. Kenny (3 shared papers)Douglas Ferguson (3 shared papers)Richard Weaver (1 shared paper)Peter J. H. Webborn (2 shared papers)Anne Cooper (3 shared papers)
- Journals
- Drug Metabolism and Disposition (10 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Pharmaceutics (2 papers)Current Drug Metabolism (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Ken Grime
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Pharmacology 603
- Oncology 410
- Computational Theory and Mathematics 207
- Pharmaceutical Science 57
- Pediatrics, Perinatology and Child Health 136
Countries citing papers authored by Ken Grime
This map shows the geographic impact of Ken Grime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Grime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Grime more than expected).
Fields of papers citing papers by Ken Grime
This network shows the impact of papers produced by Ken Grime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Grime. The network helps show where Ken Grime may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Grime, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 139 | |
| 2 | 2007 | 124 | |
| 3 | 2007 | 100 | |
| 4 | 2020 | 91 | |
| 5 | 2005 | 84 | |
| 6 | 2012 | 83 | |
| 7 | 2006 | 79 | |
| 8 | 2004 | 45 | |
| 9 | 2014 | 44 | |
| 10 | 2012 | 42 | |
| 11 | Preclinical Development Handbook: ADME and Biopharmaceutical Properties | 2007 | 32 |
| 12 | 2017 | 31 | |
| 13 | 2006 | 27 | |
| 14 | 2005 | 25 | |
| 15 | 2008 | 24 | |
| 16 | 2018 | 22 | |
| 17 | 2019 | 22 | |
| 18 | 2010 | 22 | |
| 19 | 2019 | 20 | |
| 20 | 2020 | 19 |
About Ken Grime
Ken Grime is a scholar working on Pharmacology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Spectroscopy, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (12 papers), Inhalation and Respiratory Drug Delivery (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Analytical Chemistry and Chromatography (4 papers), Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pharmacology (603 citations), Oncology (410 citations), Computational Theory and Mathematics (207 citations), Pharmaceutical Science (57 citations) and Pediatrics, Perinatology and Child Health (136 citations). Ken Grime has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Robert J. Riley, Dermot F. McGinnity, Matthew G. Soars, Jane R. Kenny, Douglas Ferguson, Richard Weaver, Peter J. H. Webborn, Anne Cooper, Anthony C. Atkinson and Stuart W. Paine. Their work appears in journals such as Drug Metabolism and Disposition, Bioorganic & Medicinal Chemistry Letters, Pharmaceutics, Current Drug Metabolism and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.